241 related articles for article (PubMed ID: 22072099)
21. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
[TBL] [Abstract][Full Text] [Related]
22. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
[TBL] [Abstract][Full Text] [Related]
24. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
Onishi H; Nouso K; Nakamura S; Katsui K; Wada N; Morimoto Y; Miyahara K; Takeuchi Y; Kuwaki K; Yasunaka T; Miyake Y; Shiraha H; Takaki A; Kobayashi Y; Sakaguchi K; Kanazawa S; Yamamoto K
Hepatol Int; 2015 Jan; 9(1):105-12. PubMed ID: 25788384
[TBL] [Abstract][Full Text] [Related]
26. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis.
He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M
Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075
[TBL] [Abstract][Full Text] [Related]
27. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB
Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870
[TBL] [Abstract][Full Text] [Related]
28. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
29. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis.
Chung YH; Song IH; Song BC; Lee GC; Koh MS; Yoon HK; Lee YS; Sung KB; Suh DJ
Cancer; 2000 May; 88(9):1986-91. PubMed ID: 10813709
[TBL] [Abstract][Full Text] [Related]
30. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.
Katamura Y; Aikata H; Takaki S; Azakami T; Kawaoka T; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Kenjo M; Toyota N; Ito K; Chayama K
J Gastroenterol; 2009; 44(5):492-502. PubMed ID: 19330281
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation.
Chuma M; Taguchi H; Yamamoto Y; Shimizu S; Nakanishi M; Ogawa K; Sho T; Horimoto H; Kobayashi T; Nakai M; Terashita K; Sakuhara Y; Abo D; Tsukuda Y; Tsunematsu S; Hige S; Kato M; Shirato H; Asaka M
J Gastroenterol Hepatol; 2011 Jul; 26(7):1123-32. PubMed ID: 21501224
[TBL] [Abstract][Full Text] [Related]
32. Significance of trans-hepatic arterial chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.
Akiyama M; Miyaaki H; Miuma S; Shibata H; Fujimoto M; Takeshita S; Ozawa E; Ichikawa T; Nakao K; Eguchi K
Oncol Rep; 2008 Aug; 20(2):353-7. PubMed ID: 18636197
[TBL] [Abstract][Full Text] [Related]
33. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.
Ishikawa T; Imai M; Kamimura H; Tsuchiya A; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T
World J Gastroenterol; 2007 Nov; 13(41):5465-70. PubMed ID: 17907289
[TBL] [Abstract][Full Text] [Related]
34. [Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].
Nagano H; Sakon M; Monden M
Nihon Rinsho; 2002 Nov; 60(11):2237-44. PubMed ID: 12440136
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma.
Ueshima K; Kudo M; Nagai T; Tatsumi C; Ueda T; Takahashi S; Hatanaka K; Kitai S; Ishikawa E; Inoue T; Hagiwara S; Minami Y; Chung H
Oncology; 2008; 75 Suppl 1():106-13. PubMed ID: 19092279
[TBL] [Abstract][Full Text] [Related]
36. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein.
Ando E; Yamashita F; Tanaka M; Tanikawa K
Cancer; 1997 May; 79(10):1890-6. PubMed ID: 9149014
[TBL] [Abstract][Full Text] [Related]
37. Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.
Uchino K; Obi S; Tateishi R; Sato S; Kanda M; Sato T; Arano T; Enooku K; Goto E; Masuzaki R; Nakagawa H; Asaoka Y; Kondo Y; Yamashiki N; Goto T; Shiina S; Omata M; Yoshida H; Koike K
J Gastroenterol; 2012 Oct; 47(10):1152-9. PubMed ID: 22438097
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
Niguma T; Mimura T; Tutui N
J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Hwang JY; Jang BK; Kwon KM; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim GC; Kim YH; Choi JS; Kwon JH
Korean J Gastroenterol; 2005 Feb; 45(2):118-24. PubMed ID: 15725716
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
Ota H; Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Nakamura M; Damdinsuren B; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
Br J Cancer; 2005 Sep; 93(5):557-64. PubMed ID: 16106266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]